ESMO 2020: UltraLow Data from the IKA Cohort
PUBLICATION: ESMO 2020 AUTHORS: Mark Opdam, Vincent van der Noort, Read More
ESMO 2020 – Hallmarks of Cancer
PUBLICATION: ESMO 2020 AUTHORS: Josien C. Haan, Rajith Bhaskaran, Lorenza Read More
Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress
Irvine, California – September 17, 2020 – Agendia, Inc., a Read More
Agendia to Showcase New Data at the European Society for Medical Oncology Virtual Congress 2020
IRVINE, Calif., Sept. 14, 2020 /CNW/ - Agendia, Inc. a world leader in Read More
Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
PUBLICATION: European Journal of Cancer AUTHORS: Laurent Jacob, Anke Witteveen, Read More
MINDACT Study Shows MammaPrint® Provides Widespread Health System Cost Savings
Analysis Published in European Journal of Cancer Use of MammaPrint Read More
Agendia Included on the 2020 Inc. 5000 List With Three-Year Revenue Growth Approaching 90%
Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Read More